The Lipid Parameters and Lipoprotein(a) Excess in Hashimoto Thyroiditis

International Journal of Endocrinology

Volumn 2015, Issue , 2015, Pages

  Yetkin, D O ^a   Dogantekin, B ^b  

^a International Hospital Istanbul   (Turkey)

^b GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THYROID HORMONE; TRIACYLGLYCEROL;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; AUTOIMMUNITY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CROSS-SECTIONAL STUDY; FEMALE; HASHIMOTO DISEASE; HUMAN; HYPOTHYROIDISM; LIPID METABOLISM; LIPOPROTEIN METABOLISM; MAJOR CLINICAL STUDY; PREMENOPAUSE; PRIORITY JOURNAL; THYROID FUNCTION TEST;

EID: 84930003625     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2015/952729     Document Type: Article

References (28)

1. C. V. Rizos, M. S. Elisaf, and E. N. Liberopoulos, "Effects of thyroid dysfunction on lipid profile," Open Cardiovascular Medicine Journal, vol. 5, pp. 76-84, 2011.
2. M. Heimberg, J. O. Olubadewo, and H. G. Wilcox, "Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states," Endocrine Reviews, vol. 6, no. 4, pp. 590-607, 1985.
3. J. Danesh, R. Collins, and R. Peto, "Lipoprotein(a) and coronary heart disease: meta-analysis of prospective studies," Circulation, vol. 102, no. 10, pp. 1082-1085, 2000.
4. J. G. Hollowell, N. W. Staehling, W. Dana Flanders et al., "Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)," Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 2, pp. 489-499, 2002.
5. M. M. Ciccone, G. De Pergola, M. T. Porcelli et al., "Increased carotid IMT in overweight and obese women affected by Hashimoto's thyroiditis: an adiposity and autoimmune linkage?" BMC Cardiovascular Disorders, vol. 10, article 22, 2010.
6. D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D. F. Treacher, and R. C. Turner, "Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man," Diabetologia, vol. 28, no. 7, pp. 412-419, 1985.
7. P. J. Stubbs, M. Seed, D. Lane, P. Collinson, F. Kendall, and M. Noble, "Lipoprotein(a) as a risk predictor for cardiac mortality in patients with acute coronary syndromes," European Heart Journal, vol. 19, no. 9, pp. 1355-1364, 1998.
8. S. Taddei, N. Caraccio, A. Virdis et al., "Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy," Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 8, pp. 3731-3737, 2003.
9. I. Klein and K. Ojamaa, "Thyroid hormone and the cardiovascular system," The New England Journal of Medicine, vol. 344, no. 7, pp. 501-509, 2001.
10. G. J. Canaris, N. R. Manowitz, G. Mayor, and E. C. Ridgway, "The colorado thyroid disease prevalence study," Archives of Internal Medicine, vol. 160, no. 4, pp. 526-534, 2000.
11. J. J. Abrams and S. M. Grundy, "Cholesterol metabolism in hypothyroidism and hyperthyroidism in man," Journal of Lipid Research, vol. 22, no. 2, pp. 323-338, 1981.
12. W.-Y. Lee, J.-Y. Suh, E.-J. Rhee, J.-S. Park, K.-C. Sung, and S.-W. Kim, "Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lp(a) levels according to thyroid function status," Archives of Medical Research, vol. 35, no. 6, pp. 540-545, 2004.
13. R. Luboshitzky, A. Aviv, P. Herer, and L. Lavie, "Risk factors for cardiovascular disease in women with subclinical hypothyroidism," Thyroid, vol. 12, no. 5, pp. 421-425, 2002.
14. F. Monzani, N. Caraccio, M. Kozàkowà et al., "Effect of levothyroxine replacement on lipid profile and intima-media thickness in subclinical hypothyroidism: a double-blind, placebo- controlled study," Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 5, pp. 2099-2106, 2004.
15. J. P. Walsh, A. P. Bremner, M. K. Bulsara et al., "Thyroid dysfuntion and serum lipids: a community-based study," Clinical Endocrinology (Oxford), vol. 63, pp. 670-675, 2005.
16. F. Toruner, A. E. Altinova, A. Karakoc et al., "Risk factors for cardiovascular disease in patients with subclinical hypothyroidism," Advances in Therapy, vol. 25, no. 5, pp. 430-437, 2008.
17. H. J. Milionis, A. P. Tambaki, C. N. Kanioglou, M. S. Elisaf, A. D. Tselepis, and A. Tsatsoulis, "Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect," Thyroid, vol. 15, no. 5, pp. 455-460, 2005.
18. X. Wanjia, W. Chenggang, W. Aihong et al., "A high normal TSH level is associated with an atherogenic lipid profile in euthyroid non-smokers with newly diagnosed asymptomatic coronary heart disease," Lipids in Health and Disease, vol. 11, article 44, 2012.
19. G. Michalopoulou, M. Alevizaki, G. Piperingos et al., "High serum cholesterol levels in persons with 'high-normal' TSH levels: should one extend the definition of subclinical hypothyroidism?" European Journal of Endocrinology, vol. 138, no. 2, pp. 141-145, 1998.
20. B. O. Asvold, T. Bjøro, and L. J. Vatten, "Associations of TSH levels within the reference range with future blood pressure and lipid concentrations: 11-year follow-up of the HUNT study," European Journal of Endocrinology, vol. 169, no. 1, pp. 73-82, 2013.
21. A. Boggio, F. Muzio, M. Fiscella, D. Sommariva, and A. Branchi, "Is thyroid-stimulating hormone within the normal reference range a risk factor for atherosclerosis in women?" Internal and Emergency Medicine, vol. 9, no. 1, pp. 51-57, 2014.
22. G. Tamer, M. Mert, I. Tamer, B. Mesci, D. Kilic, and S. Arik, "Effects of thyroid autoimmunity on abdominal obesity and hyperlipidaemia," Endokrynologia Polska, vol. 62, no. 5, pp. 421-428, 2011.
23. D. J. Rader and H. B. Brewer Jr., "Lipoprotein (a): clinical approach to a unique atherogenic lipoprotein," Journal of the American Medical Association, vol. 267, no. 8, pp. 1109-1112, 1992.
24. G. H. Dahlen, J. R. Guyton, M. Attar, J. A. Farmer, J. A. Kautz, and A. M. Gotto Jr., "Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography," Circulation, vol. 74, no. 4, pp. 758-765, 1986.
25. T. Tzotzas, G. E. Krassas, T. Konstantinidis, and M. Bougoulia, "Changes in lipoprotein(a) levels in overt and subclinical hypothyroidism before and during treatment," Thyroid, vol. 10, no. 9, pp. 803-808, 2000.
26. N. Caraccio, E. Ferrannini, and F. Monzani, "Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study," Journal of Clinical Endocrinology and Metabolism, vol. 87, no. 4, pp. 1533-1538, 2002.
27. M. Ito, J. Takamatsu, I. Sasaki et al., "Disturbed metabolism of remnant lipoproteins in patients with subclinical hypothyroidism," The American Journal of Medicine, vol. 117, no. 9, pp. 696-699, 2004.
28. H. Lotz and G. B. Salabe, "Lipoprotein (a) increase associated with thyroid autoimmunty," European Journal of Endocrinology, vol. 136, pp. 87-91, 1997.